Parkman Healthcare Partners »

Augmedix shares owned by Parkman Healthcare Partners

Quarter-by-quarter ownership of Augmedix (AUGX) shares owned by Parkman Healthcare Partners from 13F filings

Historical chart of Parkman Healthcare Partners investment in Augmedix

Tip: Access up to 7 years of quarterly data

All positions including Augmedix held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Augmedix by Parkman Healthcare Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.9M 376k 5.15

More positions owned by Parkman Healthcare Partners

Boston Scientific Corporation (BSX)
United Therapeutics Corporation (UTHR)
Becton, Dickinson and (BDX)
Dex (DXCM)
Cooper Cos Com New
AmerisourceBergen (COR)
Tenet Healthcare Corp Com New (THC)
Hca Holdings (HCA)
Vaxcyte (PCVX)
ImmunoGen
Rxsight (RXST)
Schrodinger (SDGR)
Humana (HUM)
Keros Therapeutics (KROS)
Neurocrine Biosciences (NBIX)

View all positions for Parkman Healthcare Partners

Top funds holding Augmedix

Redmile Group
Samjo Management
Divisadero Street Capital Management
Perkins Capital Management
Vanguard Group
Caption Management
Russell Investments
G2 Investment Partners Management
American Financial Group
Balyasny Asset Management
Essex Investment Management
Kennedy Capital Management
Millennium Management
Point72 Asset Management
Resolute Capital Asset Partners

View all funds holding Augmedix